Postoperative Helicobacter pylori Infection as a Prognostic Factor for Gastric Cancer Patients after Curative Resection
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Few studies have evaluated the effect of Helicobacter pylori infection on the prognosis of patients diagnosed with gastric cancer (GC) after curative surgery. We investigated the association between the H. pylori infection status and clinical outcome after surgery. Methods: We assessed the H. pylori status of 314 patients who underwent curative resection for GC. The H. pylori status was examined using a rapid urease test 2 months after resection. Patients were followed for 10 years after surgery. Results: An H. pylori infection was observed in 128 of 314 patients. The median follow-up period was 93.5 months. A Kaplan-Meier analysis indicated that patients with H. pylori had a higher cumulative survival rate than those who were negative for H. pylori. Patients with stage II cancer who tested negative for H. pylori were associated with a poor outcome. In a multivariate analysis, H. pylori-negative status was a significant independent prognostic factor for poor overall survival. Conclusions: Having a negative H. pylori infection status seems to indicate poor prognosis for patients with GC who have undergone curative resection. Further prospective controlled studies are needed to evaluate the mechanism by which H. pylori affects GC patients after curative surgery in Korea.
Abstract
Background/Aims: Few studies have evaluated the effect of Helicobacter pylori infection on the prognosis of patients diagnosed with gastric cancer (GC) after curative surgery. We investigated the association between the H. pylori infection status and clinical outcome after surgery. Methods: We assessed the H. pylori status of 314 patients who underwent curative resection for GC. The H. pylori status was examined using a rapid urease test 2 months after resection. Patients were followed for 10 years after surgery. Results: An H. pylori infection was observed in 128 of 314 patients. The median follow-up period was 93.5 months. A Kaplan-Meier analysis indicated that patients with H. pylori had a higher cumulative survival rate than those who were negative for H. pylori. Patients with stage II cancer who tested negative for H. pylori were associated with a poor outcome. In a multivariate analysis, H. pylori-negative status was a significant independent prognostic factor for poor overall survival. Conclusions: Having a negative H. pylori infection status seems to indicate poor prognosis for patients with GC who have undergone curative resection. Further prospective controlled studies are needed to evaluate the mechanism by which H. pylori affects GC patients after curative surgery in Korea.
참고문헌 (17)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2015", Cancer Research and Treatment, 47(2), pp.142~148 (2015), 대한암학회[DOI]
- Schistosomes, liver flukes and Helicobacter pylori, "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994", IARC Monogr Eval Carcinog Risks Hum, 61, pp.1~241 (1994)
- Kato S, "Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics", Cancer Sci, 98, pp.790~794 (2007)
- Lee WJ, "Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori", Br J Surg, 82, pp.802~805 (1995)
- Hobsley M, "Helicobacter pylori and gastric cancer: neither friend nor foe", Gastroenterology, 132, pp.2076~ (2007)
- Meimarakis G, "Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study", Lancet Oncol, 7, pp.211~222 (2006)
- Marrelli D, "Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer", Cancer, 115, pp.2071~2080 (2009)
- Kang SY, "Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection", Int J Cancer, 130, pp.948~958 (2012)
- Japanese Gastric Cancer Association, "Japanese gastric cancer treatment guidelines 2010 (ver. 3)", Gastric Cancer, 14, pp.113~123 (2011)
- Edge SB, "The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Correa P, "A human model of gastric carcinogenesis", Cancer Res, 48, pp.3554~3560 (1988)
- Takeda I, "Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells", J Immunol, 172, pp.3580~3589 (2004)
- Bamford KB, "Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype", Gastroenterology, 114, pp.482~492 (1998)
- Xue LJ, "Autoimmune responses induced by Helicobacter pylori improve the prognosis of gastric carcinoma", Med Hypotheses, 70, pp.273~276 (2008)
- Leung WK, "Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer", Am J Pathol, 156, pp.537~543 (2000)
- Wu MS, "Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis", Hepatogastroenterology, 49, pp.285~289 (2002)
- Rad R, "Helicobacter pylori and prognosis of gastric carcinoma", Lancet Oncol, 7, pp.364~365 (2006)